Global Polycythemia Vera Drug Market 2018 : Industry, Sales, Demand, Analysis, Opportunities and Forecast to 2025
Published: Sep-2018 | Format: PDF | Qy Research | Number of pages: 117
<pre>This report studies the global Polycythemia Vera Drug market status and forecast, categorizes the global Polycythemia Vera Drug market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).
The global Polycythemia Vera Drug market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.
The major manufacturers covered in this report
ANP Technologies, Inc.
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd.
Galena Biopharma, Inc.
Gilead Sciences, Inc.
Italfarmaco S.p.A.
Karus Therapeutics Limited
miRagen Therapeutics, Inc.
Nerviano Medical Sciences S.r.l.
Novartis AG
PharmaEssentia Corporation
Teva Pharmaceutical Industries Ltd.
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Dasatinib
Idelalisib
Givinostat
M-009
Others
By Application, the market can be split into
Clinic
Hospital
Others
The study objectives of this report are:
To analyze and study the global Polycythemia Vera Drug capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Polycythemia Vera Drug manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Polycythemia Vera Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Polycythemia Vera Drug Manufacturers
Polycythemia Vera Drug Distributors/Traders/Wholesalers
Polycythemia Vera Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Polycythemia Vera Drug market, by end-use.
Detailed analysis and profiles of additional market players.</pre>
<pre>Table of Contents
Global Polycythemia Vera Drug Market Professional Survey Report 2018
1 Industry Overview of Polycythemia Vera Drug
1.1 Definition and Specifications of Polycythemia Vera Drug
1.1.1 Definition of Polycythemia Vera Drug
1.1.2 Specifications of Polycythemia Vera Drug
1.2 Classification of Polycythemia Vera Drug
1.2.1 Dasatinib
1.2.2 Idelalisib
1.2.3 Givinostat
1.2.4 M-009
1.2.5 Others
1.3 Applications of Polycythemia Vera Drug
1.3.1 Clinic
1.3.2 Hospital
1.3.3 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of Polycythemia Vera Drug
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Polycythemia Vera Drug
2.3 Manufacturing Process Analysis of Polycythemia Vera Drug
2.4 Industry Chain Structure of Polycythemia Vera Drug
3 Technical Data and Manufacturing Plants Analysis of Polycythemia Vera Drug
3.1 Capacity and Commercial Production Date of Global Polycythemia Vera Drug Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Polycythemia Vera Drug Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Polycythemia Vera Drug Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Polycythemia Vera Drug Major Manufacturers in 2017
4 Global Polycythemia Vera Drug Overall Market Overview
4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2013-2018E Global Polycythemia Vera Drug Capacity and Growth Rate Analysis
4.2.2 2017 Polycythemia Vera Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2013-2018E Global Polycythemia Vera Drug Sales and Growth Rate Analysis
4.3.2 2017 Polycythemia Vera Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2013-2018E Global Polycythemia Vera Drug Sales Price
4.4.2 2017 Polycythemia Vera Drug Sales Price Analysis (Company Segment)
5 Polycythemia Vera Drug Regional Market Analysis
5.1 North America Polycythemia Vera Drug Market Analysis
5.1.1 North America Polycythemia Vera Drug Market Overview
5.1.2 North America 2013-2018E Polycythemia Vera Drug Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2013-2018E Polycythemia Vera Drug Sales Price Analysis
5.1.4 North America 2017 Polycythemia Vera Drug Market Share Analysis
5.2 Europe Polycythemia Vera Drug Market Analysis
5.2.1 Europe Polycythemia Vera Drug Market Overview
5.2.2 Europe 2013-2018E Polycythemia Vera Drug Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2013-2018E Polycythemia Vera Drug Sales Price Analysis
5.2.4 Europe 2017 Polycythemia Vera Drug Market Share Analysis
5.3 China Polycythemia Vera Drug Market Analysis
5.3.1 China Polycythemia Vera Drug Market Overview
5.3.2 China 2013-2018E Polycythemia Vera Drug Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2013-2018E Polycythemia Vera Drug Sales Price Analysis
5.3.4 China 2017 Polycythemia Vera Drug Market Share Analysis
5.4 Japan Polycythemia Vera Drug Market Analysis
5.4.1 Japan Polycythemia Vera Drug Market Overview
5.4.2 Japan 2013-2018E Polycythemia Vera Drug Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2013-2018E Polycythemia Vera Drug Sales Price Analysis
5.4.4 Japan 2017 Polycythemia Vera Drug Market Share Analysis
5.5 Southeast Asia Polycythemia Vera Drug Market Analysis
5.5.1 Southeast Asia Polycythemia Vera Drug Market Overview
5.5.2 Southeast Asia 2013-2018E Polycythemia Vera Drug Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2013-2018E Polycythemia Vera Drug Sales Price Analysis
5.5.4 Southeast Asia 2017 Polycythemia Vera Drug Market Share Analysis
5.6 India Polycythemia Vera Drug Market Analysis
5.6.1 India Polycythemia Vera Drug Market Overview
5.6.2 India 2013-2018E Polycythemia Vera Drug Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2013-2018E Polycythemia Vera Drug Sales Price Analysis
5.6.4 India 2017 Polycythemia Vera Drug Market Share Analysis
6 Global 2013-2018E Polycythemia Vera Drug Segment Market Analysis (by Type)
6.1 Global 2013-2018E Polycythemia Vera Drug Sales by Type
6.2 Different Types of Polycythemia Vera Drug Product Interview Price Analysis
6.3 Different Types of Polycythemia Vera Drug Product Driving Factors Analysis
6.3.1 Dasatinib Growth Driving Factor Analysis
6.3.2 Idelalisib Growth Driving Factor Analysis
6.3.3 Givinostat Growth Driving Factor Analysis
6.3.4 M-009 Growth Driving Factor Analysis
6.3.5 Others Growth Driving Factor Analysis
7 Global 2013-2018E Polycythemia Vera Drug Segment Market Analysis (by Application)
7.1 Global 2013-2018E Polycythemia Vera Drug Consumption by Application
7.2 Different Application of Polycythemia Vera Drug Product Interview Price Analysis
7.3 Different Application of Polycythemia Vera Drug Product Driving Factors Analysis
7.3.1 Clinic of Polycythemia Vera Drug Growth Driving Factor Analysis
7.3.2 Hospital of Polycythemia Vera Drug Growth Driving Factor Analysis
7.3.3 Others of Polycythemia Vera Drug Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Polycythemia Vera Drug
8.1 ANP Technologies, Inc.
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 ANP Technologies, Inc. 2017 Polycythemia Vera Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 ANP Technologies, Inc. 2017 Polycythemia Vera Drug Business Region Distribution Analysis
8.2 Bristol-Myers Squibb Company
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Bristol-Myers Squibb Company 2017 Polycythemia Vera Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Bristol-Myers Squibb Company 2017 Polycythemia Vera Drug Business Region Distribution Analysis
8.3 F. Hoffmann-La Roche Ltd.
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 F. Hoffmann-La Roche Ltd. 2017 Polycythemia Vera Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 F. Hoffmann-La Roche Ltd. 2017 Polycythemia Vera Drug Business Region Distribution Analysis
8.4 Galena Biopharma, Inc.
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Galena Biopharma, Inc. 2017 Polycythemia Vera Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Galena Biopharma, Inc. 2017 Polycythemia Vera Drug Business Region Distribution Analysis
8.5 Gilead Sciences, Inc.
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Gilead Sciences, Inc. 2017 Polycythemia Vera Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Gilead Sciences, Inc. 2017 Polycythemia Vera Drug Business Region Distribution Analysis
8.6 Italfarmaco S.p.A.
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Italfarmaco S.p.A. 2017 Polycythemia Vera Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Italfarmaco S.p.A. 2017 Polycythemia Vera Drug Business Region Distribution Analysis
8.7 Karus Therapeutics Limited
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Karus Therapeutics Limited 2017 Polycythemia Vera Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Karus Therapeutics Limited 2017 Polycythemia Vera Drug Business Region Distribution Analysis
8.8 miRagen Therapeutics, Inc.
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 miRagen Therapeutics, Inc. 2017 Polycythemia Vera Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 miRagen Therapeutics, Inc. 2017 Polycythemia Vera Drug Business Region Distribution Analysis
8.9 Nerviano Medical Sciences S.r.l.
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Nerviano Medical Sciences S.r.l. 2017 Polycythemia Vera Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Nerviano Medical Sciences S.r.l. 2017 Polycythemia Vera Drug Business Region Distribution Analysis
8.10 Novartis AG
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Novartis AG 2017 Polycythemia Vera Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Novartis AG 2017 Polycythemia Vera Drug Business Region Distribution Analysis
8.11 PharmaEssentia Corporation
8.12 Teva Pharmaceutical Industries Ltd.
9 Development Trend of Analysis of Polycythemia Vera Drug Market
9.1 Global Polycythemia Vera Drug Market Trend Analysis
9.1.1 Global 2018-2025 Polycythemia Vera Drug Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Polycythemia Vera Drug Sales Price Forecast
9.2 Polycythemia Vera Drug Regional Market Trend
9.2.1 North America 2018-2025 Polycythemia Vera Drug Consumption Forecast
9.2.2 Europe 2018-2025 Polycythemia Vera Drug Consumption Forecast
9.2.3 China 2018-2025 Polycythemia Vera Drug Consumption Forecast
9.2.4 Japan 2018-2025 Polycythemia Vera Drug Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Polycythemia Vera Drug Consumption Forecast
9.2.6 India 2018-2025 Polycythemia Vera Drug Consumption Forecast
9.3 Polycythemia Vera Drug Market Trend (Product Type)
9.4 Polycythemia Vera Drug Market Trend (Application)
10 Polycythemia Vera Drug Marketing Type Analysis
10.1 Polycythemia Vera Drug Regional Marketing Type Analysis
10.2 Polycythemia Vera Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Polycythemia Vera Drug by Region
10.4 Polycythemia Vera Drug Supply Chain Analysis
11 Consumers Analysis of Polycythemia Vera Drug
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Polycythemia Vera Drug Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source</pre>
Please submit the below form, to get more about this report:
Indicates required fields
Please fill your details below, to receive sample report:
Indicates required fields
Latest News
|
Dec-2018 |Electrical & Electronic Six Flags Has Challenged The Toughest Biometric Privacy Law Of The US
It was 2008 when Illinois released a law that after a decade stays as the toughest biometric privacy standard in the country. The BIPA (Biometric Information Privacy Act) impose tough rules on how the firms are able to gather sensitive infor ... |
|
Dec-2018 |Other Ohio Became The First State To Accept Taxes From Businesses In Bitcoin
For Long, there is been a lot of uncertainty in terms of legalities in the United States about the cryptocurrency, but Ohio took a step ahead. Recently, it has become the first state to accept Bitcoin to pay the taxes. As noted by the WSJ (Wall St ... |
|
Jan-2018 |Electrical & Electronic Study Claims That Mobile Apps Enhance Mental Health Thus Fueling The Global Smartphone Application Market
People undergoing mental health issues can reinforce their psychological well-being via mobile apps, a new survey claimed. The study, posted in the journal JMIR Mental Health, claimed that users who grapple with emotional and mental health issues ... |
|
Jan-2018 |Medical & Health Government Controlling Drugs And Prices Impacting Pharmaceuticals Market
The central government is preparing to curb the prices of combine drugs, which include 14 types of drugs. These drugs are used in the treatment of diseases such as high blood pressure, sugar, and cholesterol. The Nationa ... |
|
Jan-2018 |ICT and Media Two lakh Job In IT Sector Depicting Solid Growth In The Market
Last year, there was little interference for jobs in India but the scenario of jobs looks better in 2018. This year, there is hope for more than two lakh jobs in the information technology sector. According to data, the Indian employment ... |
Latest Reports
Customer services